- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.04 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x IOD: IODIDE ION(Non-functional Binders)
- 9 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 5 residues within 4Å:- Chain A: C.18, T.19, H.20, N.108, K.112
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:H.20
- Salt bridges: A:H.20, A:K.112
SO4.6: 2 residues within 4Å:- Chain A: D.69, N.70
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.69, A:N.70
SO4.7: 6 residues within 4Å:- Chain A: G.47, T.75, S.76, T.77, T.78, V.79
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:G.47, A:T.75, A:S.76, A:T.77, A:T.78, A:T.78, A:T.78
SO4.8: 3 residues within 4Å:- Chain A: P.62, K.64
- Chain B: K.138
3 PLIP interactions:3 interactions with chain B- Water bridges: B:E.151, B:E.151
- Salt bridges: B:K.138
SO4.11: 3 residues within 4Å:- Chain B: T.19, H.20, K.112
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:T.19, B:H.20
- Salt bridges: B:H.20, B:K.112
SO4.12: 5 residues within 4Å:- Chain B: L.21, K.112, I.115, G.116, R.119
No protein-ligand interaction detected (PLIP)SO4.13: 5 residues within 4Å:- Chain B: S.10, P.11, G.12, I.13, K.64
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.10, B:G.12
- Water bridges: B:K.64
SO4.14: 6 residues within 4Å:- Chain B: G.47, Q.48, S.76, T.77, T.78, V.79
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:S.76, B:T.77, B:T.78, B:T.78
- Water bridges: B:T.77
SO4.15: 4 residues within 4Å:- Chain B: I.13, Q.15, V.32, H.67
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.15
- Salt bridges: B:H.67
- 1 x R2A: (2-{[3-(4-{2-[(3-{[3-(carboxymethyl)-5-methyl-1-benzofuran-2-yl]ethynyl}benzene-1-carbonyl)amino]ethyl}piperazine-1-carbonyl)phenyl]ethynyl}-5-methyl-1-benzofuran-3-yl)acetic acid(Non-covalent)
R2A.16: 37 residues within 4Å:- Chain A: E.40, V.41, I.42, P.43, Q.48, E.49, A.51, Y.52, L.55, K.56, T.78, A.81, A.82, W.85, A.122, E.123, H.124, K.126, T.127, M.131
- Chain B: E.40, Q.48, E.49, A.51, Y.52, L.55, K.56, T.78, A.81, A.82, W.85, A.122, E.123, H.124, K.126, T.127, M.131
28 PLIP interactions:15 interactions with chain A, 13 interactions with chain B- Hydrophobic interactions: A:Q.48, A:E.49, A:A.51, A:L.55, A:T.78, A:A.81, A:A.82, A:K.126, A:T.127, B:Y.52, B:Y.52, B:L.55, B:T.78, B:A.82, B:T.127
- Hydrogen bonds: A:E.123, A:E.123, A:H.124, A:T.127, B:Q.48, B:E.123, B:H.124, B:K.126, B:T.127
- Salt bridges: A:E.40, A:H.124, B:H.124
- pi-Cation interactions: B:K.126
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Scanlon, M. et al., HIV Integrase core domain (IN) in complex with dimeric spanning inhibitor. To Be Published
- Release Date
- 2021-01-27
- Peptides
- Integrase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.04 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x IOD: IODIDE ION(Non-functional Binders)
- 9 x SO4: SULFATE ION(Non-functional Binders)
- 1 x R2A: (2-{[3-(4-{2-[(3-{[3-(carboxymethyl)-5-methyl-1-benzofuran-2-yl]ethynyl}benzene-1-carbonyl)amino]ethyl}piperazine-1-carbonyl)phenyl]ethynyl}-5-methyl-1-benzofuran-3-yl)acetic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Scanlon, M. et al., HIV Integrase core domain (IN) in complex with dimeric spanning inhibitor. To Be Published
- Release Date
- 2021-01-27
- Peptides
- Integrase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B